Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
批准号：
444149
负责人：
Barakat Khaled H
金额：
$37.06万
依托单位：
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
未结题
起止时间：
2021-04-01 至 2026-04-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer immunotherapy uses a patient's immune system to fight cancer. Unfortunately, until recently, most cancer immunotherapies did not work for most patients, or caused severe side effects, and almost all failed. The dream of a successful cancer immunoth
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Screening for Novel NS5B-Inhibitors: Toward Selective and Potent Hepatitis C Virus (HCV) Therapy.
-
批准号：270559
-
项目类别：Fellowship Programs
-
资助金额：$3.28万
-
财政年份：2012
-
负责人：Barakat Khaled H
-
依托单位：
海外基金
